Safety of Ultrasound Contrast Agents in Pediatric Patients With Sickle Cell Disease and Trait
Journal of Ultrasound in Medicine · 2024
DOI: 10.1002/jum.16341 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Ultrasound in Medicine, 2024. Verfasst von Aikaterini Ntoulia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Contrast Media, Anemia, Sickle Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Ultrasound contrast agent (UCA) use is increasing. Recent isolated reports observed a rise in pain‐related adverse events with the intravenous administration of the UCA Definity in adults with sickle cell disease. To date, no studies have investigated the incidence of similar adverse events with UCA Lumason or Optison. We describe our experience regarding the safety of Lumason and Optison in children with sickle cell disease and trait who underwent contrast‐enhanced ultrasound exams in our department with intravenous, intravesical, and other intracavitary routes. No pain‐related or other adverse events were observed in this pediatric population with any route of UCA administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Zitieren
APA
Ntoulia, A., Darge, K., Thompson, A. A., & Back, S. J. (2024). Safety of Ultrasound Contrast Agents in Pediatric Patients With Sickle Cell Disease and Trait. Journal of Ultrasound in Medicine. https://doi.org/10.1002/jum.16341
Vancouver
Ntoulia A, Darge K, Thompson AA, Back SJ. Safety of Ultrasound Contrast Agents in Pediatric Patients With Sickle Cell Disease and Trait. Journal of Ultrasound in Medicine. 2024. doi:10.1002/jum.16341
BibTeX
@article{Ntoulia2024,
author = {Ntoulia, Aikaterini and Darge, Kassa and Thompson, Alexis A and Back, Susan J},
title = {Safety of Ultrasound Contrast Agents in Pediatric Patients With Sickle Cell Disease and Trait},
journal = {Journal of Ultrasound in Medicine},
year = {2024},
doi = {10.1002/jum.16341}
}
EUVIMED